Atosiban, sold under the brand name Tractocile among others, is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication...
18 KB (1,708 words) - 07:18, 13 August 2024
Calcium-channel blockers (such as nifedipine) and oxytocin antagonists (such as atosiban) may delay delivery by 2 to 7 days, depending on how quickly the medication...
31 KB (2,488 words) - 04:36, 12 August 2024
beta-agonists and may also have some benefits over atosiban and magnesium sulfate, although atosiban results in fewer maternal adverse effects. No difference...
22 KB (2,026 words) - 07:11, 25 June 2024
smooth muscle to delay premature labor. While preferred over agents such as atosiban and ritodrine, its role has largely been replaced by the calcium channel...
36 KB (3,015 words) - 22:05, 30 August 2024
to facilitate birth and to stimulate milk release. The tocolytic agent atosiban (Tractocile) acts as an antagonist of oxytocin receptors. It is registered...
34 KB (3,243 words) - 23:32, 5 August 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
45 KB (4,138 words) - 10:18, 12 August 2024
gland Target tissues Wide spread Receptors Oxytocin receptor Antagonists Atosiban Precursor Oxytocin/neurophysin I prepropeptide Metabolism Liver and other...
104 KB (11,649 words) - 03:28, 28 July 2024
the induction of labour; Endometrin / Lutinus (progesterone) Tractocile (atosiban), to delay premature labor Pabal/ Duratocin/ Lonactene / Duratobal / (carbetocin)...
18 KB (1,712 words) - 13:07, 5 March 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
3 KB (269 words) - 03:16, 29 July 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
17 KB (1,518 words) - 18:20, 7 November 2023
anxiolytic in mice; possibly non-selective over vasopressin receptors Peptide Atosiban Barusiban Non-peptide Epelsiban L-368,899 (CAS# 148927-60-0) L-371,257...
22 KB (2,497 words) - 03:15, 29 July 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
92 KB (9,850 words) - 11:11, 8 September 2024
agonist or as a uterotonic. Some may oppose uterine contractility such as atosiban. Carbetocin: A long-acting synthetic analog with a half-life 4 to 10 times...
20 KB (2,321 words) - 00:01, 15 May 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
26 KB (2,496 words) - 05:45, 28 August 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
10 KB (838 words) - 01:05, 31 August 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
3 KB (407 words) - 06:08, 27 March 2022
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
11 KB (763 words) - 16:45, 26 June 2024
Cesarean section. Oxytocin receptor antagonists, such as barusiban or atosiban have the opposite effect of depressing oxytocin receptor activity and can...
21 KB (1,918 words) - 04:36, 22 July 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
10 KB (1,059 words) - 05:14, 3 June 2024
Ibuprofen G02CC02 Naproxen G02CC03 Benzydamine G02CC04 Flunoxaprofen G02CX01 Atosiban G02CX02 Flibanserin G02CX03 Agni casti fructus G02CX04 Cimicifugae rhizoma...
2 KB (301 words) - 01:47, 31 December 2022
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
30 KB (2,641 words) - 18:25, 14 August 2024
anti-inflammatory drugs, calcium channel blockers, beta mimetics, and atosiban. Tocolysis rarely delays delivery beyond 24–48 hours. This delay, however...
169 KB (19,218 words) - 22:38, 3 September 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
11 KB (974 words) - 03:10, 10 March 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
10 KB (584 words) - 05:46, 28 August 2024
(USAN) atopaxar (USAN, INN) atorolimumab (INN) Atorvaliq atorvastatin (INN) atosiban (INN) atovaquone (INN) Atozine Oral atracurium besilate (INN) atreleuton...
11 KB (530 words) - 20:38, 27 August 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
15 KB (1,714 words) - 20:29, 11 March 2024
increase the clinical pregnancy rate compared with no antibiotics. The use of Atosiban, G-CSF and hCG around the time of embryo transfer showed a trend towards...
46 KB (5,607 words) - 05:02, 16 August 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
11 KB (1,361 words) - 06:01, 27 August 2023
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
13 KB (1,043 words) - 12:10, 7 September 2024
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01...
8 KB (805 words) - 13:07, 26 July 2024